NCT05405582

Brief Summary

Study Hypothesis: Social mobilisation will attract and engage young people into decentralised sexual reproductive health (SRH) services where HIV prevention is tailored to need. Decentralised risk informed (differentiated) biosocial HIV prevention will reduce the overall prevalence of sexually transmissible HIV amongst young people aged 15-30. Study aims:

  1. 1.Measure the impact of social mobilisation into decentralised SRH services that provide tailored HIV prevention on the prevalence of transmissible HIV.
  2. 2.Evaluate the acceptability, practicability, and reach of social mobilisation and decentralised SRH with tailored HIV prevention to deliver differentiated biosocial HIV prevention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 27, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 6, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

February 2, 2024

Status Verified

February 1, 2024

Enrollment Period

2.7 years

First QC Date

May 27, 2022

Last Update Submit

February 1, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Prevalence of sexually transmitted HIV

    The proportion of those aged 15-30 who are HIV positive and have a detectable HIV viral load defined as having an HIV viral load of \>= 400 copies per ml, in the intervention arm compared to control

    36 months

  • The uptake of risk informed biomedical HIV prevention

    The proportion of participants who are aware of HIV status; on treatment if positive; and have undergone risk assessment by peer navigators or SRH clinic if HIV negative (and taken up PrEP if HIV negative and eligible) in the intervention arm compared to control.

    36 months

  • The cost of transmissible HIV averted.

    The cost per transmissible HIV case averted and the cost per case linked to risk differentiated biosocial HIV prevention.

    36 months

Secondary Outcomes (10)

  • Uptake of contraception

    36 months

  • Uptake of voluntary male medical circumcision

    36 months

  • Prevalence of Sexually Transmitted Infections

    36 months

  • Teenage pregnancy and fatherhood

    36 months

  • Proportion of men and women aged 15-30 at risk of acquiring HIV or transmitting HIV

    36 months

  • +5 more secondary outcomes

Other Outcomes (2)

  • Common mental disorder

    36 months

  • Retention in PrEP

    36 months

Study Arms (2)

community-based differentiated biosocial HIV prevention (incl. PrEP) with SRH

EXPERIMENTAL

The intervention is available to all 15-30 year olds residing in the intervention cluster. Area based peer navigators mobilise all young people living in their cluster. They provide sexual health promotion, condoms, HIV self-tests, pregnancy test, and conduct structured psychosocial and health needs assessment with the young people they support. Based on the needs assessment they develop a tailored plan which includes, varying degrees of peer-mentorship and psychosocial support, lay-counselling and ART/PrEP adherence support. The peer navigators refer young people to mobile SRH services. The mobile SRH services provide gender and HIV status neutral nurse-led HIV testing, Individualised risk assessments for HIV care and PrEP, contraception and wider SRH services. The nurses liaise with the peer navigators to provide ongoing support for 3-monthly follow-ups with repeat HIV testing, adherence support and PrEP/ART/contraception refills.

Combination Product: Community-based differentiated HIV prevention incl.PrEP with SRH

Standard of Care

ACTIVE COMPARATOR

SOC is available to all young people in the delayed clusters. Care is provided in a nurse led Primary Health Clinics (PHC) to young people who attend the clinic. This includes HIV counselling and point of care testing, immediate initiation of ART if positive and PrEP if negative and eligible according to South African National PrEP guidelines. This is followed by a 3-monthly follow-up with repeat HIV testing, safety bloods, clinic-based counselling and adherence support and PrEP/ART refills. Clinic attendees are offered family planning support and syndromic management for STIs (as per South African National Department of Health Guideline).

Other: Primary Health Clinic based HIV prevention and care

Interventions

Community-based model of care, that consists of social mobilisation by area-based peer-navigator into decentralised sexual reproductive health (SRH) and HIV care (incl. PrEP).

community-based differentiated biosocial HIV prevention (incl. PrEP) with SRH

Primary Health Clinic (PHC) based initiation and follow-up with HIV testing and standard HIV prevention and treatment package. Family planning support and syndromic management for STIs as per South African National Department of Health Guideline.

Standard of Care

Eligibility Criteria

Age15 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Resident in the cluster
  • Any gender
  • Aged 15-30
  • If aged 18-30 and able and willing to consent to participate
  • If aged 15-17, able and willing to assent and whose guardian or parent are able and willing to consent to their participation.

You may not qualify if:

  • Unable or unwilling to provide consent
  • Aged 14 or less
  • aged 31 or more

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Africa Health Research Institute

Somkele, KwaZulu-Natal, South Africa

RECRUITING

Related Publications (2)

  • Busang J, Ngoma N, Zuma T, Herbst C, Okesola N, Chimbindi N, Dreyer J, Smit T, Bird K, Mtolo L, Behuhuma O, Hanekom W, Herbst K, Lebina L, Seeley J, Copas A, Baisley K, Shahmanesh M. Person-centred HIV care and prevention for youth in rural South Africa: preliminary implementation findings from Thetha Nami ngithethe nawe stepped-wedge trial of peer-navigator mobilization into mobile sexual health services. J Int AIDS Soc. 2025 Sep;28 Suppl 5(Suppl 5):e70032. doi: 10.1002/jia2.70032.

  • Busang J, Zuma T, Herbst C, Okesola N, Chimbindi N, Dreyer J, Mtshali N, Smit T, Ngubane S, Hlongwane S, Gumede D, Jalazi A, Mdluli S, Bird K, Msane S, Danisa P, Hanekom W, Lebina L, Behuhuma N, Hendrickson C, Miot J, Seeley J, Harling G, Jarolimova J, Sherr L, Copas A, Baisley K, Shahmanesh M. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa. BMC Public Health. 2023 Aug 15;23(1):1553. doi: 10.1186/s12889-023-16262-x.

MeSH Terms

Conditions

Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Maryam Shahmanesh, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Restricted randomisation was used to randomly allocate administrative areas in equal measure (to early and delayed roll-out of the intervention steps (20:20). Restricted randomisation was used to ensure that the intervention steps are reasonably balanced with respect to key characteristics (obtained from the HDSS) specifically, adolescent and young adult population size and density, new versus old areas, and geographic location along the N2 road. Interventions were assigned during a public ceremony to ensure transparency and fairness in the randomisation and engagement of the community. Randomisation and allocation were kept separate throughout. The statistician and investigators did not participate in the public randomisation and will remain blinded until the analyses of primary and randomised secondary outcomes have been finalised. Investigators remain blinded to allocation throughout. The participants and intervention delivery teams are not blinded.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: step wedge cluster randomised controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2022

First Posted

June 6, 2022

Study Start

May 26, 2022

Primary Completion

February 1, 2025

Study Completion

May 1, 2025

Last Updated

February 2, 2024

Record last verified: 2024-02

Locations